Brno - Moravský kras je po dnešku ještě lákavějším místem k jarnímu výletu. Stovky dětí v chráněné oblasti vysbíraly odpadky po turistech a zaplnily jimi hned několik kontejnerů. Odpoledne je za ...
AstraZeneca has added to its oncology pipeline by licensing a small-molecule KRAS inhibitor from Chinese biotech Usynova for $24 million upfront. The compound – called UA022 – targets the ...
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback